Health Trials

Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1)

2

Review clinical trials related to Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD

A Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous AOC 1020 for the Treatment of Facioscapulohumeral Muscular Dystrophy (FSHD)

Participants needed: 200
Trial details
Phase: Phase 3Age: 16-70Biological sex: AllType: InterventionalSponsor: Avidity Biosciences, Inc.Updated: May 29, 2026Locations: 46
Eligibility criteria

Clinical and genetic diagnosis of FSHD1 or FSHD2 [+2]

Breastfeeding, pregnancy, or intent to become pregnant during the study [+5]

Read more
Status: Recruiting

A Registered Cohort Study on FSHD1

The data to be collected is intended to help healthcare providers make important medical and financial decisions concerning FSHD1, through an enhanced understanding of the prevalence, progression and natural history of FSHD1.

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Ning Wang, MD., PhD.Updated: Aug 26, 2024Locations: 1
Eligibility criteria

Male or female subjects of all ages at baseline [+2]

Decline to participate [+2]

Read more